EUVIMEDEUVIMED entdecken
EditorialLeitlinieOpen Access · CC BY-NC 4.0

A turning point in the prostate-specific antigen screening debate: Insights from the 2026 Cochrane update and implications for clinical guidelines

Eu Chang Hwang iD, Juan Victor Ariel Franco iD, Jae Hung Jung iD, Philipp Dahm iD

Investigative and Clinical Urology · 2026 · 67 (6) · 503

DOI: 10.4111/icu.20260392 ↗

Kurz gefasst

Editorial in der Zeitschrift Investigative and Clinical Urology, 2026. Verfasst von Eu Chang Hwang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Urology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea.
  • Cochrane Evidence Synthesis Unit Germany/UK - Düsseldorf Subunit, Institute of General Practice, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Department of Urology, Yonsei University Wonju College of Medicine, Wonju, Korea.
  • Department of Precision Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea.
  • Center of Evidence-Based Medicine, Institute of Convergence Science, Yonsei University, Seoul, Korea. geneuro95@yonsei.ac.kr.
  • Urology Section, Minneapolis VA Health Care System, Minneapolis, MN, USA.

ORCID-Profile: Eu Chang Hwang, Juan Victor Ariel Franco, Jae Hung Jung, Philipp Dahm

Zitieren

APA

Hwang, E. C., Franco, J. V. A., Jung, J. H., & Dahm, P. (2026). A turning point in the prostate-specific antigen screening debate: Insights from the 2026 Cochrane update and implications for clinical guidelines. Investigative and Clinical Urology, 67(6), 503. https://doi.org/10.4111/icu.20260392

Vancouver

Hwang EC, Franco JVA, Jung JH, Dahm P. A turning point in the prostate-specific antigen screening debate: Insights from the 2026 Cochrane update and implications for clinical guidelines. Investigative and Clinical Urology. 2026;67(6):503. doi:10.4111/icu.20260392

BibTeX
@article{Hwang2026,
  author = {Hwang, Eu Chang and Franco, Juan Victor Ariel and Jung, Jae Hung and Dahm, Philipp},
  title = {A turning point in the prostate-specific antigen screening debate: Insights from the 2026 Cochrane update and implications for clinical guidelines},
  journal = {Investigative and Clinical Urology},
  year = {2026},
  volume = {67},
  number = {6},
  pages = {503},
  doi = {10.4111/icu.20260392}
}
Kostenlos starten →